Targeted beta-globin gene conversion in human hematopoietic CD34+ and Lin−CD38− cells
Open Access
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (2) , 118-126
- https://doi.org/10.1038/sj.gt.3301610
Abstract
Chimeric oligonucleotides have been used successfully to correct point and frameshift mutations in several cell types, as well as in animal and plant models. However, their application to primitive human blood cells has been limited. In this investigation, chimeric oligonucleotides designed to direct a site-specific nucleotide exchange in the human β-globin gene (an A to T substitution within codon 6) were introduced into normal human CD34+ and Lin−CD38- cells via microinjection. This A to T nucleotide exchange introduces the single site mutation responsible for sickle cell anemia. In 23% of experimental samples, gene conversion was detected in the progeny of microinjected CD34+ and Lin−CD38− cells that were cultured for at least 4 weeks. In addition, gene conversion was detected in the erythroid progeny of Lin−CD38− cells at the mRNA level. Conversion rates as high as 10–15% in 11% (five of 44) of experimental samples were confirmed by allele-specific PCR and sequence analysis of genomic DNA from the progeny of microinjected Lin−CD38− cells. Given that as few as 10% normal hematopoietic cells are sufficient to keep patients free of sickle cell disease, the level of conversion we have achieved in some samples may well be of therapeutic benefit in patients with sickle cell disease.Keywords
This publication has 23 references indexed in Scilit:
- Umbilical cord blood progeny cells that retaina CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cellsTransfusion, 2001
- High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene deliveryGene Therapy, 2000
- In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotideNature Biotechnology, 2000
- Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotideNature Biotechnology, 2000
- Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extractNucleic Acids Research, 1999
- Homologous Recombination Based Gene TherapyNephron Experimental Nephrology, 1999
- Targeted gene repairGene Therapy, 1999
- Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotideNature Biotechnology, 1998
- Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotideHepatology, 1997
- Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA OligonucleotideScience, 1996